Reaktionsgleichung
[CH3:1][C:2]1[S:6][C:5]([NH:7][C:8]([C:10]2[CH:11]=[CH:12][C:13]([N:16]3[CH2:21][CH2:20][CH:19]([C:22]4C=CC=C(C(F)(F)F)C=4)[CH2:18][CH2:17]3)=[N:14][CH:15]=2)=[O:9])=[N:4][C:3]=1[C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1.CC1SC(NC(C2CN(C3C=CC=CN=3)CCC2[C:59]2[N:63](C)[CH:62]=[N:61][N:60]=2)=O)=NC=1C1C=CC=CC=1.ClC1C=CC(C(NC2SC(C)=C(C3C=CC=CC=3)N=2)=O)=CN=1.CN1C=NN=C1C1CCNCC1>>[CH3:1][C:2]1[S:6][C:5]([NH:7][C:8]([C:10]2[CH:11]=[CH:12][C:13]([N:16]3[CH2:17][CH2:18][CH:19]([C:22]4[N:63]([CH3:62])[CH:59]=[N:60][N:61]=4)[CH2:20][CH2:21]3)=[N:14][CH:15]=2)=[O:9])=[N:4][C:3]=1[C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1Komponenten
5
Edukt 4
Produkt 1
Versuchsvorschrift
With a method similar to that used for the preparation of 4-(3-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyridinyl-5′-carboxylic acid (5-methyl-4-phenyl-thiazol-2-yl)-amide, 4-(4-methyl-4H-[1,2,4]triazol-3-yl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyridinyl-5-carboxylic acid (5-methyl-4-phenyl-thiazol-2-yl)-amide was prepared from 6-chloro-N-(5-methyl-4-phenyl-thiazol-2-yl)-nicotinamide and 4-(4-methyl-4H-[1,2,4]triazol-3-yl)-piperidine. LCMS calcd for C24H25N7OS (m/e) 459, obsd 460 (M+H).
Quellen und Nachweise
- ORD-Eintrag
- ord-1fe5b422e379465eb16e49d1ed9da86e
- Quelldatensatz
- uspto-grants-2012_12
- Patentnummer
- US08324385B2
Verknüpfte Notizen
Wird geladen…